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Prostaglandins (PG) are detected in virtually all organs and
cells, whereas their enhanced release follows inflammatory
mechanisms. PG synthesis, especially of PGE2, PGD2 and
PGF2a, also takes place in epidermal keratinocytes as a
result of arachidonic acid (AA) metabolism (Kondoh et al,
1985; Pentland and Needleman, 1986) and is differentially
supported by specific enzymatic systems, the constitutively
expressed cyclooxygenase (COX)-1 and the inducible COX-
2 (Holtzman et al, 1994). Several mediators, such as phorbol
myristate acetate, calcium ionophore A23187, melittin,
bradykinin, epidermal growth factor, 1-oleoyl-2-acetyl glyc-
erol platelet-activating factor (synthetic analog of diacyl-
glycerol), cholecalciferol, interleukin-1, and tumor growth
factor-a have been shown to activate this pathway (Kondoh
et al, 1985; Fairley et al, 1986; Kvedar and Levine, 1987;
Fisher et al, 1989; Pentland and Mahoney, 1990; Hanke
et al, 1996; Kanekura et al, 1998). Exogenous PG regulate
major keratinocyte functions, i.e., inhibit or stimulate prolif-
eration in vitro under different culture conditions (Harper,
1976; Sugita et al, 1986), modify cyclic nucleotide levels
(Wilkinson and Orenberg, 1979), and enhance calcium-in-
duced cornification (Evans et al, 1993). Endogenous PG
have been shown to enhance keratinocyte proliferation
(Pentland and Needleman, 1986). On the other hand, fib-
roblasts are less responsive to PG pathway activators,
whereas keratinocytes can activate fibroblasts to produce
prostocyclin which is a paracrine prodifferentiating agent for
keratinocytes (Baden et al, 1992).
Despite the abundant knowledge on the PG pathway in
keratinocytes, little is known on its activity in sebaceous
gland cells, which represent differentiated epithelial cells.
PG synthesis, especially that of PGD2 and PGE2, has been
detected in mouse sebaceous gland cells (Henke et al,
1986). In 1998, Ma et al reported a major finding: estrogen
treatment, which induces peroxisome proliferation in the
uropygial gland in the duck, also enhanced AA metabolism
in this organ. Conversion of PGD2 to the natural PGJ2 me-
tabolite, D12-PGJ2, was induced by estradiol treatment pre-
ceding peroxisome proliferation. Exogenous D12-PGJ2 and
15-deoxy-D12,14-PGJ2 activated the peroxisome prolifera-
tors-activated receptor (PPAR)-g1, being, therefore, its nat-
ural ligands. On the other hand, Neufang et al (2001) have
shown that in a COX-2 overexpressing mouse, PG accu-
mulation occurs, the skin exhibits a preneoplastic pheno-
type, and that sebaceous gland hyperplasia, increased
sebum levels, sparse coat of greasy hair, and hyperplasia of
scale epidermis due to a disturbed program of epidermal
differentiation are present. These data confirmed previous
results by Rosenfield et al (1998) that PPAR-g1 ligands in-
duce lipid accumulation in mouse preputial gland cells
in vitro. In addition, the latter group has shown that exogenous
carbaprostacyclin (cPGI2), stable prostocyclin analogue and
a natural PPAR-d/-a ligand, significantly induced lipid-form-
ing colonies in mouse preputial gland cells in vitro and that
retinoid X receptor agonists amplified the effect of cPGI2
(Kim et al, 2001). Proliferation of the mouse preputial gland
cells was also enhanced significantly by cPGI2. Interesting-
ly, AA induces accumulation of lipids in human sebaceous
gland cells in vitro (Wro´bel et al, 2003) and downregulation
PPAR-a through selective ligands has currently been sug-
gested to be involved in the development of seborrhea and
acne (Zouboulis et al, 2003, 2005).
In this issue, Iwata et al (2005) close the knowledge gap
by providing evidence that 15-deoxy-D12,14-PGJ2 augments
the formation of lipid droplets in hamster auricle sebaceous
gland cells in vitro. This effect occurs due to a diacylglycerol
acyltransferase-triggered increase of triacylglycerol synthe-
sis, which indicates sebaceous gland cell differentiation,
and is accompanied by an increase of the relative levels
of 15-deoxy-D12,14-PGJ2 to PGF2a and PGE2. Hamster au-
ricle sebaceous gland cells were found to constitutively
produce COX-2 but not COX-1, whereas human facial se-
baceous gland cells constitutively produce both COX-2
and COX-1 (Alestas et al, in press). Although COX inhibi-
tion by indomethacin, diclofenac or NS-398 led to an ex-
pected reduction of PGF2a and PGE2 production, synthesis
of 15-deoxy-D12,14-PGJ2 increased, and triacylglycerol syn-
thesis was also enhanced. Triacylglycerol synthesis was
also enhanced in the presence of the PPAR-g1 ligand trog-
litazone. Similarly, topical administration of indomethacin to
hamster auricles was found to cause the development of
sebaceous glands with the augmentation of sebum depo-
sition in vivo. The indomethacim and NS-398-augmented
15-deoxy-D12,14-PGJ2 production and triacylglycerol syn-
thesis here suppressed by a nonselective cytochrome
P-450 inhibitor, which did not affect the similar troglitazone
effect.
This fascinating work provides a number of links in un-
derstanding the biological role of the PG pathway in seba-
ceous gland cells: a) COX-2 and a still unknown cytochrome
P-450 enzyme—downstream to PGD synthase—exhibit op-
posite effects. Therefore, COX-2 inhibitors reduce PGF2a
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and PGE2 levels but increase 15-deoxy-D
12,14-PGJ2 pro-
duction and triacylglycerol synthesis. The clinical conse-
quence could be that COX-2 inhibition may lead to a
downregulation of an existing inflammatory reaction but
may also enhance seborrhoea; and b) both natural and
synthetic PPAR-g1 ligands enhance lipid synthesis in seba-
ceous gland cells following different modes of action, which
for the natural PPAR-g1 ligand 15-deoxy-D12,14-PGJ2 is the
regulation of a cytochrome P-450 enzyme.
In addition, the results of this study combined with the
results of the previous reports mentioned above give a partial
explanation of the rather complex sebotropic effect of est-
rogens (Callens et al, 1996; Dieudonne et al, 2000). Estrogens
seem to upregulate 15-deoxy-D12,14-PGJ2 synthesis and sub-
sequently enhance PPAR-g1 activity and sebaceous lipid syn-
thesis (Ma et al, 1998; Iwata et al, 2005). This pathway of
estrogen effectiveness is probably complementary to estro-
gen’s capacity to upregulate the insulin-like growth factor-1
pathway and, subsequently, production of sebaceous lipids
(Makrantonaki et al, 2002; Mendez-Davila et al, 2004).
At last, the work of Iwata et al (2005) provides indirect
evidence that the inhibition of the lipoxygenase pathway,
which exhibits proinflammatory and sebotropic activities
and a possible regulation of PPAR-a (Alestas et al, in press;
Zouboulis et al, 2003, 2005) is likely to be more powerful
than the inhibition of the PG pathway, including PPAR-g1
regulation, for future treatments of seborrhea and acne. On
the other hand, manipulating the PG pathway may be of
great interest in improving the activity of aging sebaceous
glands by parallel downregulation of inflammatory signals,
thus improving the quality of aging skin.
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